コンパニオンアニマルヘルス市場規模、シェア、動向分析レポート：動物別、製品別、流通チャネル別、最終用途別、地域別、セグメント予測、2024年～2030年

コンパニオンアニマルヘルス市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、コンパニオンアニマルヘルスの世界市場規模は、予測期間中にCAGR 9.3％を記録し、2030年までに425億米ドルに達すると予測されています。

市場は、研究開発プログラムの増加、政府イニシアティブの数の増加、ペットの採用の増加、獣医手術の高いボリュームとコンパニオンアニマルの慢性疾患の有病率によって駆動される.獣医医療部門は、COVID-19パンデミックの間に多くの課題を経験している.獣医師はシャットダウンにもかかわらず、まだ働くことができました。米国、英国、フランス、ブラジルの3,000人以上のペットの飼い主を対象とした調査によると、4分の1以上の飼い主が、パンデミックが始まって以来、病気の感染を恐れて、獣医師との連絡を先延ばしにしたり、避けたりしています。

さらに、飼い主の大多数（65％）は、パンデミックが薬や処置へのアクセスに悪影響を及ぼすことはなかったと回答しています。米国獣医師会によると、米国では約70％の世帯（9,050万世帯）がペットを飼っており、犬や猫が最も一般的な犬種です。また、ペットを飼う個人の増加に伴い、ペット薬に対する需要が高まっていることも市場を牽引しています。コンパニオンアニマル用医薬品の市場は、質の高い獣医療に対する需要の増加によっても牽引されています。獣医療の研究開発活動は、過去10年間に着実に増加しました。ペットに使用する外科手術や特殊な薬のセグメントでは、数多くの技術革新があった。市場のリーダーとしての地位を確立するため、大手企業は戦略的に斬新な技術を取り入れています。

例えば、2022年1月、FDAはZoetis初の変形性関節症に対するモノクローナル抗体治療Solensiaを承認しました。これと同様に、同社は犬の関節炎の痛みを軽減するモノクローナル抗体Librelaをリリースしています。近年、フランスのような国ではペットの疾病の流行が増加しており、ペット治療の需要が高まっています。肥満、歯の問題、皮膚アレルギー、変形性関節症、ウイルス性疾患は、フランスで最も典型的なペットの病気です。ペットの健康と幸福を維持するための薬と予防医療の必要性は、フランスにおけるペットの病気の有病率の上昇によって強調されています。さらに、医薬品とワクチンの需要の高まりが市場をさらに押し上げると予測されています。フランス動物用医薬品庁（ANMV）のような動物用医薬品の安全性を保証する政府機関の存在が、市場の成長に寄与しています。

コンパニオンアニマルヘルス市場レポートハイライト

• 製品別では、医薬品セグメントが2023年に44.43%以上の圧倒的シェアを占めました。動物の寿命延長を助ける医薬品の採用は、ペット飼育の顕著な増加によって加速しています。
• 特に新興国市場でペットの医療コストが上昇した結果、犬セグメントが2023年に40.0%超のシェアを占めました。
• 流通チャネル別では、病院薬局セグメントが2023年に47%超の最大シェアを占めました。ペットの飼育率の上昇により、動物病院やクリニックの世界の利用可能性が高まっています。
• 病院・クリニックの最終用途セグメントは、2023年に80％超の圧倒的シェアを占めました。これは、革新的なインフラを備えた動物病院やクリニックが世界中で拡大しているためです。セグメントの成長に影響を与えるもう一つの側面は、獣医師の数の増加です。
• 北米は2023年に市場全体の35.82%のシェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 コンパニオンアニマルヘルス市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• コンパニオンアニマルヘルス市場分析ツール
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析
  • パイプライン分析

第4章 コンパニオンアニマルヘルス市場：動物、推定・動向分析

• 世界のコンパニオンアニマルヘルス市場：動物ダッシュボード
• 世界のコンパニオンアニマルヘルス市場：動物変動分析
• 世界のコンパニオンアニマルヘルス市場：動物別、収益別
• 犬
• 馬
• 猫
• その他

第5章 コンパニオンアニマルヘルス市場：製品、推定・動向分析

• 世界のコンパニオンアニマルヘルス市場：製品ダッシュボード
• 世界のコンパニオンアニマルヘルス市場：製品変動分析
• 製品別、収益別
• ワクチン
• 医薬品
• 飼料添加物
• 診断
• その他

第6章 コンパニオンアニマルヘルス市場：流通チャネル、推定・動向分析

• 世界のコンパニオンアニマルヘルス市場：流通チャネルダッシュボード
• 世界のコンパニオンアニマルヘルス市場：流通チャネル変動分析
• 流通チャネル別、収益
• 小売
• eコマース
• 病院薬局

第7章 コンパニオンアニマルヘルス市場：最終用途、推定・動向分析

• 世界のコンパニオンアニマルヘルス市場：最終用途ダッシュボード
• 世界のコンパニオンアニマルヘルス市場：最終用途変動分析
• 世界のコンパニオンアニマルヘルス市場推定・予測最終用途、収益
• ポイントオブケア/社内試験
• 病院・クリニック
• その他

第8章 コンパニオンアニマルヘルス市場：動物、製品、流通チャネル、最終用途別の地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 企業/競合の分類
• ベンダー情勢
  • 主要企業の市場シェア分析、2023年
• 企業プロファイル
  • Agrolabo SpA
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd.
  • Merck &Co., Inc.
  • Norbrook
  • Vetoquinol
  • Virbac
  • Zoetis Services LLC

List of Tables

• Table 1 List of abbreviation
• Table 2 North America companion animal health market, by region, 2018 - 2030 (USD Million)
• Table 3 North America companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 4 North America companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 5 North America companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 6 North America companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 7 U.S companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 8 U.S companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 9 U.S companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 10 U.S companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 11 Canada companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 12 Canada companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 13 Canada companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 14 Canada companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 15 Mexico companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 16 Mexico companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 17 Mexico companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 18 Mexico companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 19 Europe companion animal health market, by region, 2018 - 2030 (USD Million)
• Table 20 Europe companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 21 Europe companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 22 Europe companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 23 Europe companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 24 Germany companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 25 Germany companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 26 Germany companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 27 Germany companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 28 UK companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 29 UK companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 30 UK companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 31 UK companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 32 France companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 33 France companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 34 France companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 35 France companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 36 Italy companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 37 Italy companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 38 Italy companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 39 Italy companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 40 Spain companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 41 Spain companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 42 Spain companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 43 Spain companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 44 Denmark companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 45 Denmark companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 46 Denmark companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 47 Denmark companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 48 Sweden companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 49 Sweden companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 50 Sweden companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 51 Sweden companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 52 Norway companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 53 Norway companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 54 Norway companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific companion animal health market, by region, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 60 China companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 61 China companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 62 China companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 63 China companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 64 Japan companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 65 Japan companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 66 Japan companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 67 Japan companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 68 India companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 69 India companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 70 India companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 71 India companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 72 South Korea companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 73 South Korea companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 74 South Korea companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 75 South Korea companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 76 Australia companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 77 Australia companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 78 Australia companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 79 Australia companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 80 Thailand companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 81 Thailand companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 82 Thailand companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 83 Thailand companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 84 Latin America companion animal health market, by region, 2018 - 2030 (USD Million)
• Table 85 Latin America companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 86 Latin America companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 87 Latin America companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 88 Latin America companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 89 Brazil companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 90 Brazil companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 91 Brazil companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 92 Brazil companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 93 Argentina companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 94 Argentina companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 95 Argentina companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 96 Argentina companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 97 MEA companion animal health market, by region, 2018 - 2030 (USD Million)
• Table 98 MEA companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 99 MEA companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 100 MEA companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 101 MEA companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 102 South Africa companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 103 South Africa companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 104 South Africa companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 105 South Africa companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 106 Saudi Arabia companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 110 UAE companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 111 UAE companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 112 UAE companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 113 UAE companion animal health market, by end - use, 2018 - 2030 (USD Million)
• Table 114 Kuwait companion animal health market, by animal, 2018 - 2030 (USD Million)
• Table 115 Kuwait companion animal health market, by product, 2018 - 2030 (USD Million)
• Table 116 Kuwait companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
• Table 117 Kuwait companion animal health market, by end - use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value - chain - based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Companion animal health market: market outlook
• Fig. 14 Companion animal health competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Companion animal health market driver impact
• Fig. 18 Companion animal health market restraint impact
• Fig. 19 Companion animal health market: Animal movement analysis
• Fig. 20 Companion animal health market: Animal outlook and key takeaways
• Fig. 21 Dogs market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Equine market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Cats market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Companion animal health market: Product movement analysis
• Fig. 26 Companion animal health market: Product outlook and key takeaways
• Fig. 27 Vaccines market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 OTC market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Feed Additives market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Companion animal health market: Distribution Channel movement analysis
• Fig. 35 Companion animal health market: Distribution Channel outlook and key takeaways
• Fig. 36 Retail market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 E - commerce market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Companion animal health market: End - use movement analysis
• Fig. 40 Companion animal health market: End - use outlook and key takeaways
• Fig. 41 Point - of - care/In - house testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Global Companion animal health market: Regional movement analysis
• Fig. 45 Global Companion Animal Health market: Regional outlook and key takeaways
• Fig. 46 Global Companion Animal Health market share and leading players
• Fig. 47 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 U.S key country dynamics
• Fig. 49 U.S market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Canada key country dynamics
• Fig. 51 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Mexico key country dynamics
• Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 UK key country dynamics
• Fig. 56 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Germany key country dynamics
• Fig. 58 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 France key country dynamics
• Fig. 60 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Italy key country dynamics
• Fig. 62 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Spain key country dynamics
• Fig. 64 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Denmark key country dynamics
• Fig. 66 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Sweden key country dynamics
• Fig. 68 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Norway key country dynamics
• Fig. 70 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 China key country dynamics
• Fig. 73 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Japan key country dynamics
• Fig. 75 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 India key country dynamics
• Fig. 77 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Thailand key country dynamics
• Fig. 79 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 South Korea key country dynamics
• Fig. 81 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Australia key country dynamics
• Fig. 83 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Brazil key country dynamics
• Fig. 86 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Argentina key country dynamics
• Fig. 88 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 South Africa key country dynamics
• Fig. 91 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Saudi Arabia key country dynamics
• Fig. 93 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 UAE key country dynamics
• Fig. 95 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Kuwait key country dynamics
• Fig. 97 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Market share of key market players - companion animal health market

Companion Animal Health Market Growth & Trends:

The global companion animal health market size is expected to reach USD 42.50 billion by 2030, registering a CAGR of 9.3% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by rising research and development programs, growing numbers of government initiatives, increasing adoption of pets, and high volumes of veterinary surgeries & prevalence of chronic diseases in companion animals.The veterinary healthcare sector has experienced many challenges during the COVID-19 pandemic.Veterinarians could still work despite the shutdown. According to a survey of more than 3,000 pet owners in the U.S., UK, France, and Brazil, more than a quarter of pet owners have put off or avoided contacting their veterinarians since the pandemic started due to the fear of disease transmission.

Moreover, the majority of owners (65 percent) concur that the pandemic had no negative effects on access to medications and procedures.An increase in pet ownership is one of the major factors driving the market. Approximately 70% of households (90.5 million homes) in the U.S. have a pet, with dogs and cats being the most common breeds, according to the American Veterinary Medical Association. The market is also being driven by rising demand for pet medicine as more individuals own pets. The market for companion animal medication is also being driven by an increase in the demand for high-quality veterinarian care. Veterinary research and development activities have steadily increased during the last decade. There were numerous innovations in the fields of surgery and specialized medications for use in pets. To establish themselves as market leaders, major players are strategically integrating novel technologies.

For instance, in January 2022, the FDA approved Zoetis' first monoclonal antibody treatment for osteoarthritis, Solensia, which is intended to reduce pain in cats with the condition. Similar to this, the company has released Librela, a monoclonal antibody to lessen canine arthritic pain.In recent years, pet disease prevalence has increased in countries like France, which has increased the demand for pet treatment. Obesity, dental issues, skin allergies, osteoarthritis, and viral diseases are the most typical pet illnesses in France. The need for medications and preventive care to keep pets healthy and happy is highlighted by the rising prevalence of pet ailments in France. In addition, it is projected that the rising pharmaceutical and vaccine demand will further boost the market. The presence of government agencies that ensure the safety of veterinary pharmaceuticals, such as the French Agency for Veterinary Medicinal Products (ANMV), contributes to the growth of the market.

Companion Animal Health Market Report Highlights:

• By product, the pharmaceuticals segment held a dominant share of over 44.43% in 2023. The introduction of medications to aid in extending animal lifespan has been accelerated by a notable rise in pet ownership
• The dogs segment dominated the market with a share of over 40.0% in 2023 as a result of rising pet healthcare costs, particularly in developed regions
• By distribution channel, the hospital pharmacies segment held the largest share of over 47% in 2023.The global availability of veterinary clinics and hospital services has increased due to the rising pet adoption rate
• The hospitals & clinics end-use segment held a dominant share of over 80% in 2023. This is due to an expansion of veterinary hospitals and clinics with innovative infrastructure around the world. Another aspect influencing the segment growth is a rise in the number of veterinarians
• North America held a 35.82% share of the overall market in 2023

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Animal
  • 1.2.2. Product
  • 1.2.3. Distribution Channel
  • 1.2.4. End-Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Animal Outlook
  • 2.2.2. Product Outlook
  • 2.2.3. Distribution Channel Outlook
  • 2.2.4. End-use Outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Companion Animal Health Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing pet ownership
    • 3.2.1.2. The rise of pet insurance
    • 3.2.1.3. Growing preference for personalized pet care
    • 3.2.1.4. Advancements in animal healthcare technology
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced veterinary treatments
    • 3.2.2.2. Increasing cost of animal testing and veterinary care
• 3.3. Companion Animal Health Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pipeline Analysis

Chapter 4. Companion Animal Health Market: Treatment Estimates & Trend Analysis

• 4.1. Global Companion Animal Health Market: Animal Dashboard
• 4.2. Global Companion Animal Health Market: Animal Movement Analysis
• 4.3. Global Companion Animal Health Market by Animal, Revenue
• 4.4. Dogs
  • 4.4.1. Dogs market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Equine
  • 4.5.1. Equine market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Cats
  • 4.6.1. Cats market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Companion Animal Health Market: Product Estimates & Trend Analysis

• 5.1. Global Companion Animal Health Market: Product Dashboard
• 5.2. Global Companion Animal Health Market: Product Movement Analysis
• 5.3. Global Companion Animal Health Market Estimates and Forecasts, By Product, Revenue (USD Million)
• 5.4. Vaccines
  • 5.4.1. Vaccines market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Pharmaceuticals
  • 5.5.1. Pharmaceuticals market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.2. OTC
    • 5.5.2.1. OTC market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.3. Prescription
    • 5.5.3.1. Prescription market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Feed Additives
  • 5.6.1. Feed Additives market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Diagnostics
  • 5.7.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Companion Animal Health Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Global Companion Animal Health Market: Distribution Channel Dashboard
• 6.2. Global Companion Animal Health Market: Distribution Channel Movement Analysis
• 6.3. Global Companion Animal Health Market Estimates and Forecasts by Distribution Channel, Revenue (USD Million)
• 6.4. Retail
  • 6.4.1. Retail market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. E-commerce
  • 6.5.1. E-commerce market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Hospital pharmacies
  • 6.6.1. Hospital pharmacies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Companion Animal Health Market: End -use Estimates & Trend Analysis

• 7.1. Global Companion Animal Health Market: End-use Dashboard
• 7.2. Global Companion Animal Health Market: End-use Movement Analysis
• 7.3. Global Companion Animal Health Market Estimates and Forecasts End-use, Revenue (USD Million)
• 7.4. Point-of-care/ In-house testing
  • 7.4.1. Point-of-care/ In-house testing estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Hospitals & clinics
  • 7.5.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Companion Animal Health Market: Regional Estimates & Trend Analysis by Animal, Product, Distribution Channel and End-use

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Vendor Landscape
  • 9.2.1. List of key distributors and channel partners
  • 9.2.2. Key customers
  • 9.2.3. Key company market share analysis, 2023
• 9.3. Company Profile
  • 9.3.1. Agrolabo S.p.A
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. Boehringer Ingelheim International GmbH
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Ceva
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. Elanco
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. IDEXX Laboratories, Inc.
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Indian Immunologicals Ltd.
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Merck & Co., Inc.
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Norbrook
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Vetoquinol
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Virbac
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Zoetis Services LLC
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives